Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
LAMTOR1 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody has been used in 5 publications
Supplier: Novus Biologicals NBP189909
Description
LAMTOR1 Polyclonal specifically detects LAMTOR1 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
c11orf59/LAMTOR1 | |
Polyclonal | |
Immunohistochemistry 1:200 - 1:500, Immunocytochemistry/Immunofluorescence 0.25-2 ug/ml, Immunohistochemistry-Paraffin 1:500 - 1:1000 | |
chromosome 11 open reading frame 59, FLJ20625, LAMTOR1, Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1, late endosomal/lysosomal adaptor, MAPK and MTOR activator 1, Lipid raft adaptor protein p18, p18, p27kip1 releasing factor from RhoA, p27Kip1-releasing factor from RhoA, p27RF-RhoC11orf59, PDRO, PDROPdro, Protein associated with DRMs and endosomes, ragulator complex protein PDRO, Ragulator1, RhoA activator C11orf59 | |
Rabbit | |
Affinity Purified | |
RUO | |
Primary | |
Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
Unconjugated | |
PBS (pH 7.2) and 40% Glycerol with 0.02% Sodium Azide | |
LAMTOR1 | |
This antibody was developed against Recombinant Protein corresponding to amino acids:NEDSDQDREERKLLLDPSSPPTKALNGAEPNYHSLPSARTDEQALLSSILAKTASNIIDVSAADSQGMEQHEYMDRARQYSTRLAVLSSSLTHWKKLPPLPSLTSQPHQVLASEPIPFSDLQQVSRIAAYAYSALSQIRVDAKEELVV | |
0.1 mL | |
Cancer | |
55004 | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction